Clinical significance of Koebner phenomenon in vitiligo
Notice that GSH goes up for low estradiol values, reaches a peak and descends for high estradiol values Variation of GSH steady state depending on S In our model, we take the activation of GCL and GPX by estradiol to be 80%, which is a reasonable choice supported by the experimental and clinical data discussed above
Self-pay option is a very attractive option, Dr
From Treatment to Trend: The Expanding Reach of GLP-1RAs We are now witnessing the widening of indications and demand, including: Non-diabetic obesity Polycystic ovary syndrome (PCOS) Fatty liver disease Cardiovascular risk reduction Off-label use for wellness or cosmetic weight loss This broadening scope presents opportunities and risks
Ferroptotic cardiomyocyte-derived exosomes promote cardiac macrophage M1 polarization during myocardial infarction
At the same time, compelling cardiovascular outcomes data will be equally critical for commercial success to demonstrate value to health systems: Novos SELECT trial read out in 2023, demonstrating the impact of Wegovy-induced weight loss was a statistically significant 20% reduction in a composite endpoint consisting of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke in 17,604 overweight or obese patients with prior cardiovascular disease
![Physiologic effects of GLP-1 (adapted from Granata et al. [11])](https://www.researchgate.net/publication/359199250/figure/fig1/AS:11431281081130351@1661532031197/Physiologic-effects-of-GLP-1-adapted-from-Granata-et-al-11.png)
